Neuren Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 4, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,672	1,588	3,178	1,001	475	147
Market Cap Growth	-3.23%	-50.04%	217.33%	110.87%	222.46%	-40.72%
Enterprise Value	1,372	1,374	3,092	970	457	138
Last Close Price	13.20	12.50	24.97	7.95	3.77	1.28
PE Ratio	11.50	11.18	20.23	5442.54	-	-
Forward PE	51.87	19.45	32.20	19.55	135.13	-
PS Ratio	7.64	7.32	13.70	64.96	148.54	205.40
PB Ratio	5.17	4.36	15.49	24.08	12.10	6.09
P/TBV Ratio	5.17	4.36	15.49	24.08	12.10	6.09
P/FCF Ratio	12.15	-	17.19	279.73	-	-
P/OCF Ratio	12.15	-	17.18	278.25	-	-
EV/Sales Ratio	6.27	6.34	13.33	62.94	142.84	192.61
EV/EBITDA Ratio	7.45	7.67	15.52	-	-	-
EV/EBIT Ratio	7.45	7.67	15.52	-	-	-
EV/FCF Ratio	9.97	-	16.73	271.04	-	-
Asset Turnover	0.78	0.66	1.59	0.37	0.10	0.04
Quick Ratio	40.42	8.69	5.68	24.59	47.58	33.13
Current Ratio	40.42	8.73	5.78	25.77	49.87	33.13
Return on Equity (ROE)	54.96%	49.92%	127.30%	0.46%	-24.57%	-48.32%
Return on Assets (ROA)	41.13%	34.05%	85.52%	-1.10%	-15.83%	-27.98%
Return on Invested Capital (ROIC)	605.76%	235.12%	-	-37.74%	-663.42%	-117453.33%
Return on Capital Employed (ROCE)	56.90%	49.20%	97.10%	-1.80%	-21.00%	-36.40%
Earnings Yield	8.92%	8.95%	4.94%	0.02%	-1.64%	-6.24%
FCF Yield	8.23%	-0.71%	5.82%	0.36%	-2.10%	-5.49%
Buyback Yield / Dilution	0.98%	-0.01%	-1.44%	-8.76%	-10.71%	-6.88%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.